Metabolic epigenome targeting hits KMT2A-rearranged acute lymphoblastic leukemia
Not available.
Saved in:
| Main Authors: | Dirk Heckl, Eva Rettinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KMT2A-rearranged acute lymphoblastic leukaemia
by: Rishi S. Kotecha, et al.
Published: (2024-12-01) -
KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges
by: Janine Stutterheim, et al.
Published: (2025-04-01) -
Revumenib as A New Therapeutic Intervention for Relapsed or Refractory KMT2A-Rearranged Acute Lymphoblastic Leukemia
by: Khushbakht Baloch, et al.
Published: (2025-04-01) -
S-adenosylmethionine addiction confers sensitivity to methionine restriction in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia
by: Trisha Tee, et al.
Published: (2025-04-01) -
Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies
by: Sara Zehtabcheh, et al.
Published: (2025-05-01)